Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis.

Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis.

Bibliographic Details
Main Authors:	Harney, S, Timperley, J, Daly, C, Harin, A, James, T, Brown, M, Banning, A, Fox, K, Donnelly, S, Wordsworth, B
Format:	Journal article
Language:	English
Published:	2006

Similar Items

Brain natriuretic peptide (BNP) is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis (RA)
by: Harney, S, et al.
Published: (2005)

Genetic epidemiology of rheumatoid arthritis.
by: Harney, S, et al.
Published: (2002)

Molecular genetics of rheumatoid arthritis.
by: Harney, S, et al.
Published: (2003)

ESTIMATION AND TREATMENT OF CARDIOVASCULAR DISEASE IN A PROSPECTIVE COHORT OF RA PATIENTS-HOW WELL ARE WE DOING?
by: Harney, S, et al.
Published: (2003)

A review of the MHC genetics of rheumatoid arthritis.
by: Newton, J, et al.
Published: (2004)

HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.
by: Harney, S, et al.
Published: (2005)

Non-inherited maternal HLA alleles are associated with rheumatoid arthritis.
by: Harney, S, et al.
Published: (2003)

Role of PADI4 in rheumatoid arthritis
by: Harney, S, et al.
Published: (2004)

Genetic and genomic studies of PADI4 in rheumatoid arthritis.
by: Harney, S, et al.
Published: (2005)

NON-INHERITED MATERNAL ANTIGENS INFLUENCE SUSCEPTIBILITY TO RHEUMATOID ARTHRITIS
by: Harney, S, et al.
Published: (2002)

Cardiovascular natriuretic peptides in emergency
by: Martina Zaninotto, et al.
Published: (2005-10-01)

Gene expression profiling of treatment response to anti-TNF-alpha therapy in rheumatoid arthritis
by: Meisel, C, et al.
Published: (2004)

MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients.
by: Harrison, P, et al.
Published: (2007)

Challenges in mapping non-HLA-DRB1 major histocompatibility genes in rheumatoid arthritis: comment on the article by Vignal et al.
by: Brown, M, et al.
Published: (2009)

Non-DRB1 MHC genes associated with rheumatoid arthritis are also differentially expressed
by: Harney, S, et al.
Published: (2005)

Natriuretic peptide system and cardiovascular disease
by: Federico Cacciapuoti
Published: (2010-01-01)

Editorial: Natriuretic Peptides in Cardiovascular Pathophysiology
by: Massimo Volpe, et al.
Published: (2022-05-01)

IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
by: I. G. Kirillova, et al.
Published: (2018-07-01)

Subclinical left ventricular dysfunction and N-terminal pro-brain natriuretic peptide in patients with rheumatoid arthritis
by: I. G. Kirillova, et al.
Published: (2022-11-01)

Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic
by: Prabhakar Singh, et al.
Published: (2020-01-01)

Natriuretic Peptide and Cardiovascular Risk: Is It About “U”?
by: Christopher R. deFilippi, et al.
Published: (2015-05-01)

Rheumatoid arthritis.
by: Wordsworth, P
Published: (1992)

Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis.
by: Newton, J, et al.
Published: (2004)

Genomic and genetic analysis suggests involvement of MHC class III genes in rheumatoid arthritis
by: Harney, S, et al.
Published: (2005)

MHC class III genes in rheumatoid arthritis and the differential association of HLA-DRB1 alleles with disease
by: Harney, S, et al.
Published: (2005)

The immunogenetics of rheumatoid arthritis.
by: Wordsworth, P
Published: (1990)

Roles of Natriuretic Peptides and the Significance of Neprilysin in Cardiovascular Diseases
by: Hitoshi Nakagawa, et al.
Published: (2022-07-01)

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases
by: A. Ya. Panarina, et al.
Published: (2024-11-01)

HLA-DRB1 influence on anti-TNF treatment in British Caucasian rheumatoid arthritis patients
by: Harrison, P, et al.
Published: (2006)

Natriuretic Peptides
by: Selim Demirtaş, et al.
Published: (2014-12-01)

The immunogenetics of rheumatoid arthritis.
by: Wordsworth, B, et al.
Published: (1992)

Progress in the immunogenetics of rheumatoid arthritis.
by: Wordsworth, P
Published: (1995)

Potential applications of natriuretic peptide system in cardiovascular regenerative medicine
by: M. Öztop
Published: (2022-05-01)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
by: Héctor Fernández‐Susavila, et al.
Published: (2017-12-01)

Effects of interleukin-1 polymorphisms on susceptibility and clinical characteristics of British caucasian rheumatoid arthritis patients
by: Harrison, P, et al.
Published: (2008)

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
by: Simone Vink, et al.
Published: (2023-03-01)

Polygenic susceptibility in rheumatoid arthritis.
by: Wordsworth, B, et al.
Published: (1991)

Identification of a Non-HLA-DRB1 genetic effect in a 100kb interval in the MHC class III region in rheumatoid arthritis.
by: Harney, S, et al.
Published: (2003)

T cell genetics and rheumatoid arthritis (RA)
by: Wordsworth, P
Published: (1998)

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs
by: I G Kirillova, et al.
Published: (2016-05-01)